AFLD 2007 FFR vs Respondent M22

Facts
The French Rugby Federation (Fédération Française de Rugby, FFR) charges respondent M22 for a violation of the Anti-Doping Rules. During a match on November 4, 2006, a sample was taken for doping test purposes. The sample tested positive on salbutamol which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent had mentioned the use of a pharmaceutical product containing salbutamol. He uses this product to treat his asthma from which he suffers since childhood. The panel regards the prescription for the product and the information from his medical files as a legitimate justification for the use of the product.

Decision
1. The respondent is acquitted.
2. The decision, dated January 16, 2007, of the disciplinary committee of the FFR doesn't need to be modified.
3. The decision will start on the date of notification.
4. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
22 February 2007
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acquittal
Sport/IFs
Rugby (WR) - World Rugby
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Rugby (FFR) - French Rugby Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S3. Beta-2 Agonists
Substances
Salbutamol
Medical terms
Asthma
Legitimate Medical Treatment
Document type
Pdf file
Date generated
23 July 2014
Date of last modification
15 August 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin